HER-2 overexpression is associated with rapid tumor growth, metastasis as well as poor prognosis of gastric cancer while the activated HER-2 not only contributes to tumor survival signals but also facilitates reprogramming of cancer cells metabolism 3. The gene discussed is ERBB2; the disease is cancer.